1. Home
  2. DCTH vs TITN Comparison

DCTH vs TITN Comparison

Compare DCTH & TITN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • TITN
  • Stock Information
  • Founded
  • DCTH 1988
  • TITN 1980
  • Country
  • DCTH United States
  • TITN United States
  • Employees
  • DCTH N/A
  • TITN N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • TITN Other Specialty Stores
  • Sector
  • DCTH Health Care
  • TITN Consumer Discretionary
  • Exchange
  • DCTH Nasdaq
  • TITN Nasdaq
  • Market Cap
  • DCTH 388.3M
  • TITN 387.3M
  • IPO Year
  • DCTH N/A
  • TITN 2007
  • Fundamental
  • Price
  • DCTH $11.10
  • TITN $16.11
  • Analyst Decision
  • DCTH Strong Buy
  • TITN Buy
  • Analyst Count
  • DCTH 4
  • TITN 4
  • Target Price
  • DCTH $24.50
  • TITN $22.25
  • AVG Volume (30 Days)
  • DCTH 681.8K
  • TITN 238.1K
  • Earning Date
  • DCTH 11-07-2025
  • TITN 11-25-2025
  • Dividend Yield
  • DCTH N/A
  • TITN N/A
  • EPS Growth
  • DCTH N/A
  • TITN N/A
  • EPS
  • DCTH 0.06
  • TITN N/A
  • Revenue
  • DCTH $70,240,000.00
  • TITN $2,580,509,000.00
  • Revenue This Year
  • DCTH $159.22
  • TITN N/A
  • Revenue Next Year
  • DCTH $42.78
  • TITN N/A
  • P/E Ratio
  • DCTH $197.68
  • TITN N/A
  • Revenue Growth
  • DCTH 491.35
  • TITN N/A
  • 52 Week Low
  • DCTH $8.08
  • TITN $12.50
  • 52 Week High
  • DCTH $18.23
  • TITN $23.41
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 45.00
  • TITN 28.01
  • Support Level
  • DCTH $10.43
  • TITN $15.85
  • Resistance Level
  • DCTH $11.28
  • TITN $16.92
  • Average True Range (ATR)
  • DCTH 0.41
  • TITN 0.66
  • MACD
  • DCTH -0.02
  • TITN -0.13
  • Stochastic Oscillator
  • DCTH 23.22
  • TITN 6.10

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About TITN Titan Machinery Inc.

Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through the following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.

Share on Social Networks: